 |
|
|
|
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 |
Actonel® (risedronate sodium)
|
 |
Asacol® (mesalamine)
|
 |
DORYX® (doxycycline hyclate) Delayed-Release
|
 |
Dovonex® (calcipotriene), 0.005%
|
 |
Enablex® (darifenacin)
|
 |
ERYC® (Erythromycin delayed-release capsules, USP)
|
 |
ESTRACE® Tablets (estradiol tablets, USP)
|
 |
ESTRACE® Cream (estradiol vaginal cream, USP, 0.01%)
|
 |
ESTROSTEP® Fe (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets)
|
 |
FEMCON® Fe (norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets)
|
 |
femhrt® (norethindrone acetate / ethinyl estradiol tablets)
|
 |
Femring® (estradiol acetate vaginal ring)
|
 |
Femtrace® (estradiol acetate tablets)
|
 |
Loestrin® 24 Fe (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets)
|
|
Mandelamine® (methenamine mandelate, USP)
|
 |
Moisturel® Sensitive Skin Cleanser
|
 |
Moisturel® Therapeutic Cream
|
 |
Moisturel® Therapeutic Lotion
|
 |
OVCON® 35 (norethindrone and ethinyl estradiol tablets, USP)
|
 |
OVCON® 50 (norethindrone and ethinyl estradiol tablets, USP)
|
 |
Pyridium® (phenazopyridine hydrochloride tablets, USP)
|
 |
Sarafem® (fluoxetine hydrochloride)
|
 |
Taclonex® Ointment (calcipotriene 0.005% and betamethasone dipropionate 0.064%)
|
 |
Taclonex Scalp® Topical Suspension (calcipotriene 0.005% and betamethasone dipropionate 0.064%)
|
|
|
|
Products
www.loestrin24.com
Important Safety Information
Prescribing Information
